Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Study of the PKMYT1 Inhibitor RP-6306 in Combination With Gemcitabine for the Treatment of Advanced Solid Tumors (MAGNETIC Study)

NCT05147272 is registered in ClinicalTrials.gov with Debiopharm International SA as lead sponsor.

NCT NCT05147272
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05147272 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Study of the PKMYT1 Inhibitor RP-6306 in Combination With Gemcitabine for the Treatment of Advanced Solid Tumors (MAGNETIC Study)
Lead sponsor
Debiopharm International SA
Phase
Phase 1
Overall status
Terminated
Start date
December 16, 2021
Completion date
August 28, 2024
Enrollment
67 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

adult solid tumor